Bhupendra G Prajapati
Overview
Explore the profile of Bhupendra G Prajapati including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
216
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kumar D, Malviya R, Srivastava S, Sridhar S, Talath S, Shareef J, et al.
Infect Med (Beijing)
. 2025 Mar;
4(1):100166.
PMID: 40060189
Mpox, formerly known as monkeypox, is a zoonotic virus of the genus, with recent outbreaks of Clade I and Ib in Central Africa presenting a considerable global health threat. This...
2.
Basu B, Ash D, Dutta A, Goswami R, Dutta S, Garala K, et al.
Z Naturforsch C J Biosci
. 2025 Feb;
PMID: 40010933
In the 21st century, 75 % of women encounter vaginal malfunctions (cervicitis, mucoid ectopy, aerobic vaginitis, candidiasis, bacterial vaginosis, degenerated vaginitis, desquamative chronic vaginitis, and sexually transmitted infections) that clinically...
3.
Deorankar P, Minglani V, Prajapati B, Patel M
CNS Neurol Disord Drug Targets
. 2025 Feb;
PMID: 39966362
A recent World Health Organization report claims that along with the growing world population and emerging life prospects, the prevalence of neurological disorders is also increasing. Out of all neurological...
4.
Parashar B, Sridhar S, Kalpana , Malviya R, Prajapati B, Uniyal P
Curr Pharm Des
. 2025 Feb;
PMID: 39950456
Background: Healthcare is rapidly leveraging machine learning to enhance patient care, streamline operations, and address complex medical issues. Though ethical issues, model efficiency, and algorithmic bias exist, the COVID-19 pandemic...
5.
Singh A, Maheshwari S, Yadav J, Kumar R, Kumar R, Verma A, et al.
Chem Biodivers
. 2025 Feb;
:e202402018.
PMID: 39928755
Individual around the globe faces enormous problems from illnesses of the neurological system and the cerebrum, including neurodegenerative conditions and brain tumors. There are still no demonstrated viable treatments for...
6.
Rapuru R, Begum R, Singh S, Vellapandian C, Ali N, Alasmari A, et al.
Z Naturforsch C J Biosci
. 2025 Feb;
PMID: 39925105
A major problem in chronic kidney illnesses is renal fibrosis. This research investigates the therapeutic potential of compounds derived from (Lotus). Comprehensive screening identified these compounds, which exhibit promising binding...
7.
Doke R, Lokhande R, Chande K, Vinchurkar K, Prajapati B
Naunyn Schmiedebergs Arch Pharmacol
. 2025 Jan;
PMID: 39836251
Erdheim-Chester disease (ECD) is a rare form of non-LCH characterized by excessive accumulation of histiocytes in various tissues, leading to significant morbidity. The estimated prevalence of ECD is low, with...
8.
Kapoor D, Gaur M, Hingalajia H, Singh S, Prajapati B
Pharm Nanotechnol
. 2025 Jan;
PMID: 39835567
Polymeric nano-discs offer a promising and adaptable nanocarrier platform for topical applications involving the targeted administration of drugs. These biocompatible polymer-based, disc-shaped, nanoscale structures have drawn interest due to their...
9.
Kedar P, Bhattacharya S, Sakore P, Prajapati B
Curr Med Chem
. 2025 Jan;
PMID: 39819540
Targeted therapy for colorectal cancer (CRC) appears to have great potential with lipid nanoparticles (LNPs). The advances in LNP-based techniques, such as liposomes, exosomes, micelles, solid lipid nanoparticles (SLNs), nano-cubosomes,...
10.
Kedar P, Bhattacharya S, Kanugo A, Prajapati B
Curr Med Chem
. 2025 Jan;
PMID: 39817387
Therapeutic hurdles persist in the fight against lung cancer, although it is a leading cause of cancer-related deaths worldwide. Results are still not up to par, even with the best...